These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience. Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349 [TBL] [Abstract][Full Text] [Related]
23. A comparison of magnetic resonance imaging techniques used to secure biopsies in prostate cancer patients. van Luijtelaar A; Bomers J; Fütterer J Expert Rev Anticancer Ther; 2019 Aug; 19(8):705-716. PubMed ID: 31277551 [No Abstract] [Full Text] [Related]
24. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer]. Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051 [TBL] [Abstract][Full Text] [Related]
25. A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies. Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS Urol Int; 2017; 99(4):384-391. PubMed ID: 28651247 [TBL] [Abstract][Full Text] [Related]
26. Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy. Xu G; Li JH; Xiang LH; Yang B; Chen YC; Sun YK; Zhao BH; Wu J; Sun LP; Xu HX Asian J Androl; 2023; 25(3):410-415. PubMed ID: 36348578 [TBL] [Abstract][Full Text] [Related]
27. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies. Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274 [TBL] [Abstract][Full Text] [Related]
28. Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer? Gold SA; Hale GR; Bloom JB; Smith CP; Rayn KN; Valera V; Wood BJ; Choyke PL; Turkbey B; Pinto PA World J Urol; 2019 Feb; 37(2):235-241. PubMed ID: 29785491 [TBL] [Abstract][Full Text] [Related]
29. Magnetic Resonance and Ultrasound Image Fusion Supported Transperineal Prostate Biopsy Using the Ginsburg Protocol: Technique, Learning Points, and Biopsy Results. Hansen N; Patruno G; Wadhwa K; Gaziev G; Miano R; Barrett T; Gnanapragasam V; Doble A; Warren A; Bratt O; Kastner C Eur Urol; 2016 Aug; 70(2):332-40. PubMed ID: 26995327 [TBL] [Abstract][Full Text] [Related]
30. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153 [TBL] [Abstract][Full Text] [Related]
31. Multiparametric MRI in detection and staging of prostate cancer. Boesen L Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [TBL] [Abstract][Full Text] [Related]
32. Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches. Warlick C; Futterer J; Maruf M; George AK; Rastinehad AR; Pinto PA; Bosaily AE; Villers A; Moore CM; Mendhiratta N; Taneja SS; Ukimura O; Konety BR World J Urol; 2019 Mar; 37(3):419-427. PubMed ID: 29943220 [TBL] [Abstract][Full Text] [Related]
33. Image-guided multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsy augmented with a sextant versus an extended template random biopsy: Comparison of cancer detection rates, complication and functional outcomes. Adams ES; Deivasigamani S; Kotamarti S; Wolf S; Mottaghi M; Aminsharifi A; Taha T; Seguier D; Michael Z; Ivey M; Gupta RT; Polascik TJ Prostate; 2024 Sep; 84(13):1224-1233. PubMed ID: 38926139 [TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer. Shoji S Investig Clin Urol; 2019 Jan; 60(1):4-13. PubMed ID: 30637355 [TBL] [Abstract][Full Text] [Related]
35. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer. Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899 [TBL] [Abstract][Full Text] [Related]
36. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer. Mozer P; Rouprêt M; Le Cossec C; Granger B; Comperat E; de Gorski A; Cussenot O; Renard-Penna R BJU Int; 2015 Jan; 115(1):50-7. PubMed ID: 24552477 [TBL] [Abstract][Full Text] [Related]
37. Targeted Biopsy With Reduced Number of Cores: Optimal Sampling Scheme in Patients Undergoing Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Prostate Biopsy. Shen WW; Cui LG; Ran WQ; Sun Y; Jiang J; Pei XL; Chen W Ultrasound Med Biol; 2020 May; 46(5):1197-1207. PubMed ID: 32107089 [TBL] [Abstract][Full Text] [Related]
38. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. Valerio M; Donaldson I; Emberton M; Ehdaie B; Hadaschik BA; Marks LS; Mozer P; Rastinehad AR; Ahmed HU Eur Urol; 2015 Jul; 68(1):8-19. PubMed ID: 25454618 [TBL] [Abstract][Full Text] [Related]
39. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer. Winoker JS; Wajswol E; Falagario U; Maritini A; Moshier E; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR Urology; 2020 Dec; 146():278-286. PubMed ID: 32956688 [TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging-guided biopsies may improve diagnosis in biopsy-naive men with suspicion of prostate cancer. Winther MD; Balslev I; Boesen L; Logager V; Noergaard N; Thestrup KD; Thomsen HS Dan Med J; 2017 May; 64(5):. PubMed ID: 28552089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]